Current advances in the generation of human iPS cells: implications in cell-based regenerative medicine

Journal of Tissue Engineering and Regenerative Medicine
Ana RevillaIsabel Liste

Abstract

Over the last few years, the generation of induced pluripotent stem cells (iPSCs) from human somatic cells has proved to be one of the most potentially useful discoveries in regenerative medicine. iPSCs are becoming an invaluable tool to study the pathology of different diseases and for drug screening. However, several limitations still affect the possibility of applying iPS cell-based technology in therapeutic prospects. Most strategies for iPSCs generation are based on gene delivery via retroviral or lentiviral vectors, which integrate into the host's cell genome, causing a remarkable risk of insertional mutagenesis and oncogenic transformation. To avoid such risks, significant advances have been made with non-integrative reprogramming strategies. On the other hand, although many different kinds of somatic cells have been employed to generate iPSCs, there is still no consensus about the ideal type of cell to be reprogrammed. In this review we present the recent advances in the generation of human iPSCs, discussing their advantages and limitations in terms of safety and efficiency. We also present a selection of somatic cell sources, considering their capability to be reprogrammed and tissue accessibility. From a translational...Continue Reading

References

Nov 6, 1998·Science·J A ThomsonJ M Jones
Dec 24, 2005·Nature Reviews. Cancer·Benjamin D Rowland, Daniel S Peeper
Jun 8, 2007·Nature·Keisuke OkitaShinya Yamanaka
Nov 22, 2007·Science·Junying YuJames A Thomson
Dec 7, 2007·Nature Biotechnology·Masato NakagawaShinya Yamanaka
Feb 22, 2008·Proceedings of the National Academy of Sciences of the United States of America·W E LowryK Plath
Jul 3, 2008·Nature Biotechnology·Marius WernigRudolf Jaenisch
Sep 6, 2008·The Journal of Gene Medicine·Sam Laurel StephenStefan Kochanek
Sep 27, 2008·Science·Matthias StadtfeldKonrad Hochedlinger
Oct 11, 2008·Science·Keisuke OkitaShinya Yamanaka
Oct 22, 2008·Nature Biotechnology·Trond AasenJuan Carlos Izpisúa Belmonte
Mar 21, 2009·Blood·Yuin-Han LohGeorge Q Daley
Apr 7, 2009·Cell·Shinya Yamanaka
Apr 29, 2009·Cell Stem Cell·Hongyan ZhouSheng Ding
May 22, 2009·Proceedings of the National Academy of Sciences of the United States of America·Federico GonzalezJuan Carlos Izpisua Belmonte
Aug 12, 2009·Nature·Han LiManuel Serrano
Sep 1, 2009·Nature·Jeong Beom KimHans R Schöler
Oct 3, 2009·Stem Cells and Development·Xing YanGeorge T-J Huang
Oct 3, 2009·Cell Stem Cell·Alessandra GiorgettiJuan Carlos Izpisua Belmonte
Oct 3, 2009·Cell Stem Cell·Alexandra HaaseUlrich Martin
Oct 7, 2009·Proceedings of the National Academy of Sciences of the United States of America·Ning SunJoseph C Wu
Oct 20, 2009·Proceedings of the Japan Academy. Series B, Physical and Biological Sciences·Noemi FusakiMamoru Hasegawa
Dec 29, 2009·Cell Stem Cell·Miguel Angel EstebanDuanqing Pei
Jan 12, 2010·Trends in Cell Biology·Tongbiao Zhao, Yang Xu
Feb 9, 2010·Nature Methods·Fangjun JiaJoseph C Wu

❮ Previous
Next ❯

Citations

Jul 21, 2015·Seminars in Cancer Biology·Jochen UtikalHeike Allgayer
Jun 11, 2015·Journal of Cellular Physiology·Seyed Hossein BassirGiuseppe Intini
Oct 18, 2018·Physiological Reviews·Peter KaragiannisKenji Osafune
Sep 14, 2018·Current Stem Cell Research & Therapy·Ali GolchinAbdolreza Ardeshirylajimi
Apr 27, 2019·Reviews in the Neurosciences·Ahmad MehdipourAbbas Ebrahimi-Kalan
Feb 20, 2019·Journal of Medical Ethics·Akira AkabayashiNancy S Jecker
Jul 30, 2020·Stem Cells International·Mengyuan WangHongzhi Fang
Aug 7, 2019·Genes to Cells : Devoted to Molecular & Cellular Mechanisms·Rika TeshigawaraTakashi Tada
Jan 11, 2020·Frontiers in Molecular Neuroscience·Mitsuto SatoYoshitsugu Aoki
Jul 7, 2020·Engineering in Life Sciences·Takumi InuiKenjiro Takemura
Jul 19, 2017·Current Rheumatology Reports·Makeda K StephensonWarren L Grayson
Oct 12, 2017·Stem Cells and Development·Guoliang MengDerrick E Rancourt
Sep 2, 2020·International Journal of Molecular Sciences·Cristina OlgasiAntonia Follenzi
Jun 2, 2018·Burns and Trauma·Zhe Li, Peter Maitz
Sep 4, 2021·3 Biotech·Amita Ajit, Indu Ambika Gopalankutty

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antiparasitics

Antiparasitics are medications which are indicated for the treatment of parasitic diseases. Discover the latest research on antiparasitics here.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Cell-Type Specific Viral Vectors

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

Cell-Type-Specific Viral Vectors (ASM)

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

Cell Fate Conversion By mRNA

mRNA-based technology is being studied as a potential technology that could be used to reprogram cell fate. This technique provides the potential to generate safe reprogrammed cells that can be used for clinical applications. Here is the latest research on cell fate conversion by mRNA.

Cell-Type-Specific Viral Vectors

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.